Jul 2, 2026 04:19AM
Jun 25, 2026 04:01PM
Jun 23, 2026 08:46AM
Jun 23, 2026 04:40AM
Jun 22, 2026 12:27PM
May 6, 2026 08:03AM
Apr 6, 2026 06:41AM Taysha Gene Therapies (TSHA) PT Raised to $17 at Canaccord
Mar 25, 2026 07:22AM
Mar 19, 2026 04:32PM
Mar 19, 2026 01:54PM
Jan 6, 2026 10:31AM
Jan 6, 2026 08:02AM
Dec 17, 2025 05:28AM
Dec 4, 2025 05:08AM Goldman Sachs Upgrades Taysha Gene Therapies (TSHA) to Buy
Nov 14, 2025 07:26AM
Nov 5, 2025 05:11AM
Nov 4, 2025 08:33AM
Nov 4, 2025 07:04AM
Oct 20, 2025 04:10PM
Oct 17, 2025 07:15AM
Oct 16, 2025 04:02PM Taysha Gene Therapies regains full rights to TSHA-102 Rett syndrome program
Oct 13, 2025 04:41AM
Oct 2, 2025 01:04PM
Sep 22, 2025 07:19AM
Sep 12, 2025 04:11AM
Aug 13, 2025 06:23AM
Aug 12, 2025 08:04AM
Jul 11, 2025 06:37AM BofA Securities Starts Taysha Gene Therapies (TSHA) at Buy
Jun 13, 2025 07:11AM
Jun 12, 2025 07:24AM
Jun 3, 2025 05:26PM
Jun 3, 2025 06:59AM
May 29, 2025 08:01AM
May 29, 2025 04:12AM
May 28, 2025 04:02PM Taysha Gene Therapies (TSHA) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
May 28, 2025 04:01PM
May 15, 2025 03:33PM
May 15, 2025 08:02AM
Apr 28, 2025 07:17AM
Apr 28, 2025 05:37AM
Mar 31, 2025 07:25AM
Jan 6, 2025 02:00PM 7 top biotech picks for 2025 according to Wells Fargo
Nov 15, 2024 07:07AM
Nov 13, 2024 04:03PM
Nov 12, 2024 07:58AM
Nov 5, 2024 06:12AM
Aug 14, 2024 10:16AM
Aug 14, 2024 06:33AM
Aug 12, 2024 08:04AM Taysha Gene Therapies (TSHA) Tops Q2 EPS by 7c
Jul 1, 2024 07:13AM

429,217 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All